Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Early research (Phase 1)Ended earlyNCT03597282
What this trial is testing

A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
BioNTech US Inc. 22
Testing effectiveness (Phase 2)Study completedNCT00003362
What this trial is testing

Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Post-approval studies (Phase 4)UnknownNCT04261179
What this trial is testing

Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer

Who this might be right for
Head CancerNeck CancerMelanoma+1 more
Anna Cruceta 30
Early research (Phase 1)Ended earlyNCT06285097
What this trial is testing

PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Who this might be right for
NeoplasmsNon-small-cell Lung CancerMelanoma+5 more
Pfizer 9
Early research (Phase 1)Study completedNCT02516527
What this trial is testing

Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid Tumors

Who this might be right for
Melanoma
Bristol-Myers Squibb 25
Testing effectiveness (Phase 2)Study completedNCT00249262
What this trial is testing

Taxoprexin Treatment for Advanced Skin Melanoma

Who this might be right for
Metastatic Melanoma
American Regent, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Very early researchActive Not RecruitingNCT05279027
What this trial is testing

Zr89 + PET Companion Trial

Who this might be right for
Melanoma (Skin)
Abramson Cancer Center at Penn Medicine 6
Testing effectiveness (Phase 2)Study completedNCT02500576
What this trial is testing

Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7+1 more
M.D. Anderson Cancer Center 18
Not applicableEnded earlyNCT05061940
What this trial is testing

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Who this might be right for
Head and Neck CancerMelanomaHPV-Related Malignancy+5 more
Repertoire Immune Medicines 22
Testing effectiveness (Phase 2)Study completedNCT01983124
What this trial is testing

Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on Vemurafenib

Who this might be right for
Malignant Melanoma Stage IV
Paola Queirolo 31
Not applicableStudy completedNCT00518050
What this trial is testing

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

Who this might be right for
MelanomaSurvivorsPsychological Factors
Memorial Sloan Kettering Cancer Center 160
Large-scale testing (Phase 3)Not Yet RecruitingNCT07552597
What this trial is testing

Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II

Who this might be right for
Melanoma (Skin Cancer)
Vastra Gotaland Region 254
Not applicableUnknownNCT04025424
What this trial is testing

Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519)

Who this might be right for
MelanomaSquamous Cell Lung CancerUveal Melanoma+1 more
Russian Academy of Medical Sciences 350
Very early researchWithdrawnNCT04891718
What this trial is testing

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Who this might be right for
Solid Tumour
Presage Biosciences
Testing effectiveness (Phase 2)Study completedNCT02038218
What this trial is testing

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors

Who this might be right for
Primary Brain TumorsMetastatic Malignant Neoplasm to Brain
DEKK-TEC, Inc. 29
Large-scale testing (Phase 3)Ended earlyNCT01264874
What this trial is testing

MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients

Who this might be right for
Melanoma
European Institute of Oncology 150
Early research (Phase 1)Looking for participantsNCT06398418
What this trial is testing

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultSolid TumorMelanoma+3 more
Rise Therapeutics LLC 33
Testing effectiveness (Phase 2)UnknownNCT01782508
What this trial is testing

A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 40
Next Page